Stock Research for RDHL

RDHL

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

RDHL Stock Chart & Research Data

The RDHL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RDHL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


RDHL Due diligence Resources & Stock Charts

The RDHL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View RDHL Detailed Price Forecast - CNN Money CNN View RDHL Detailed Summary - Google Finance
Yahoo View RDHL Detailed Summary - Yahoo! Finance Zacks View RDHL Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View RDHL Trends & Analysis - Trade-Ideas Barrons View RDHL Major Holders - Barrons
NASDAQ View RDHL Call Transcripts - NASDAQ Seeking View RDHL Breaking News & Analysis - Seeking Alpha
Spotlight View RDHL Annual Report - CompanySpotlight.com OTC Report View RDHL OTC Short Report - OTCShortReport.com
TradeKing View RDHL Fundamentals - TradeKing Charts View RDHL SEC Filings - Bar Chart
WSJ View Historical Prices for RDHL - The WSJ Morningstar View Performance/Total Return for RDHL - Morningstar
MarketWatch View the Analyst Estimates for RDHL - MarketWatch CNBC View the Earnings History for RDHL - CNBC
StockMarketWatch View the RDHL Earnings - StockMarketWatch MacroAxis View RDHL Buy or Sell Recommendations - MacroAxis
Bullish View the RDHL Bullish Patterns - American Bulls Short Pains View RDHL Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View RDHL Stock Mentions - StockTwits PennyStocks View RDHL Stock Mentions - PennyStockTweets
Twitter View RDHL Stock Mentions - Twitter Invest Hub View RDHL Investment Forum News - Investor Hub
Yahoo View RDHL Stock Mentions - Yahoo! Message Board Seeking Alpha View RDHL Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for RDHL - SECform4.com Insider Cow View Insider Transactions for RDHL - Insider Cow
CNBC View RDHL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for RDHL - OTC Markets
Yahoo View Insider Transactions for RDHL - Yahoo! Finance NASDAQ View Institutional Holdings for RDHL - NASDAQ


Stock Charts

FinViz View RDHL Stock Insight & Charts - FinViz.com StockCharts View RDHL Investment Charts - StockCharts.com
BarChart View RDHL Stock Overview & Charts - BarChart Trading View View RDHL User Generated Charts - Trading View




Latest Financial News for RDHL


RedHill closes $20M public offering to prep commercialization of new drug
Posted on Wednesday December 12, 2018

RedHill Biopharma just closed on a $20 million public offering to fund the commercial launch of its drug, Talicia – which means expansion of the company's Raleigh team.


RedHill Biopharma Announces Closing of $20 Million Underwritten Offering
Posted on Tuesday December 11, 2018

TEL-AVIV, Israel and RALEIGH, N.C., Dec. 11, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on proprietary drugs for gastrointestinal diseases, today announced the closing of its previously announced underwritten public offering for a total number of 2,857,143 American Depositary Shares (“ADSs”), each representing ten of its ordinary shares, at a public offering price of $7.00 per ADS. The Company has also granted the underwriters a 30-day option to purchase up to 428,571 additional ADSs at the public offering price.


RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering
Posted on Thursday December 06, 2018

TEL-AVIV, Israel and RALEIGH, N.C., Dec. 06, 2018 -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty.


RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares
Posted on Tuesday December 04, 2018

TEL-AVIV, Israel and RALEIGH, N.C., Dec. 04, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on proprietary drugs for gastrointestinal diseases, today announced that it intends to offer its American Depositary Shares (“ADSs”), each representing ten of its ordinary shares, in an underwritten public offering. The Company also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ADSs offered to the public. The Company intends to use the net proceeds from the offering, together with its existing cash and cash equivalents, to fund preparations for TALICIA® (H. pylori) commercial launch and commercialization activities, clinical development programs, including initiation of a pivotal Phase III study with RHB-204 for NTM, preparations for a second Phase III study with RHB-104 for Crohn’s disease and for acquisitions and general corporate purposes.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.